EGFR and neoplasm: This would be of most use in clinical situations where HGG cells from a single tumor have mixed expression of EGFR and its mutants,25 where intratumoral regions mosaically express different somatic profiles1, 2 or in tumors displaying mixed HGG subtypes, which are associated with poorer prognoses.26